As a company dedicated to pursuit of regenerative medicine approaches for sensory-related diseases, Caeregen Therapeutics applies leading-edge science and technologies to the discovery and development of novel therapies to repair, restore, and protect diseased or damaged sensory and neurologic structures. We are a pre-clinical company advancing one of our first discoveries, Noregen™, a synthetic protein modeled after human norrin, a naturally occurring protein that guides retinal vascular formation in fetal development. Our work demonstrates that Noregen™ targets the progressive loss of the tiny capillary vessels and may promote their organized re-growth as well as that of neuronal and ganglion cells responsible for conducting light to the optic nerve that can contribute to vision restoration.